Oxidative stress in small-for-gestational age (SGA) term newborns and their mothers

Free Radical Research

Volumn 43, Issue 4, 2009, Pages 376-384

  Gveric Ahmetasevic, Snjezana ^a   Sunjic, Suzana Borovic ^b   Skala, Hana ^c   Andrisic, Luka ^b   Stroser, Marina ^a   Zarkovic, Kamelija ^a   Skrablin, Snjezana ^a   Tatzber, Franz ^d   Cipak, Ana ^b   Jaganjac, Morana ^b   Waeg, Georg ^e   Gveric, Tugomir ^f   Zarkovic, Neven ^b  

^a KBC Zagreb   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

^c SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^d Dr Tatzber KEG   (Austria)

^e UNIVERSITY OF GRAZ   (Austria)

^f Croatian Academy of Medical Sciences   (Croatia)

Author keywords

4 hydroxynonenal; Antioxidants; Appropriate for gestational age newborns; Lipid peroxidation; Malondialdehyde; Oxidative stress; Peroxide; Small for gestational age

Indexed keywords

4 HYDROXYNONENAL; MALONALDEHYDE; PEROXIDE; 4-HYDROXY-2-NONENAL; ALDEHYDE; ANTIOXIDANT;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; ENZYMATIC ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MATERNAL SERUM; MOTHER; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERINATAL PERIOD; PLACENTA; SMALL FOR DATE INFANT; STROMA; UMBILICAL ARTERY; UMBILICAL VEIN; BIRTH; BLOOD; CASE CONTROL STUDY; FETUS BLOOD; METABOLISM; NEWBORN; PREGNANCY;

ADULT; ALDEHYDES; ANTIOXIDANTS; CASE-CONTROL STUDIES; FEMALE; FETAL BLOOD; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; LIPID PEROXIDATION; MALONDIALDEHYDE; OXIDATIVE STRESS; PARTURITION; PEROXIDES; PLACENTA; PREGNANCY; YOUNG ADULT;

EID: 67650110707     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760902783285     Document Type: Article

References (47)

1. Grune, T. and Berger, M. (2007) Markers of oxidative stress in ICU clinical settings: Present and future. Curr Opinions Clin Nutr Metab Care, 10, pp. 712-717.
2. Rattan, SIS. (2006) Theories of biological aging: Genes, proteins and free radicals. Free Radic Res, 40, pp. 1230-1238.
3. Humphries, KM, Szwezda, PA and Szwezda, LI. (2006) Aging: A shift from redox regulation to oxidative damage. Free Radic Res, 40, pp. 1239-1243.
4. Widmer, R., Ziaja, I. and Grune, T. (2006) Protein oxidation and degradation during aging: Role in skin aging and neurodegeneration. Free Radic Res, 40, pp. 1259-1268.
5. Borovic Sunjic, S, Cipak, A., Rabuzin, F., Wildburger, R. and Zarkovic, N. (2005) The influence of 4-hydroxy-2-nonenal on proliferation, differentiation and apoptosis of human osteosarcoma cells. BioFactors, 24, pp. 141-148.
6. Zarkovic, N., Zarkovic, K., Schaur, RJ, Stolc, S., Schlag, G., Redl, H., Waeg, G., Borovic, S., Loncaric, I., Juric, G. and Hlavka, V. (1999) 4-hydroxynonenal as a second messenger of free radicals and growth modifying factor. Life Sci, 65, pp. 1901-1904.
7. Esterbauer, H., Schaur, RJ and Zollner, H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic Biol Med, 11, pp. 81-128.
8. Zarkovic, N. (2003) 4-hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Asp Med, 24, pp. 281-291.
9. Uchida, K. (2003) 4-hydroxy-2-nonenal: A product and mediator of oxidative stress. Prog Lipid Res, 42, pp. 1-26.
10. Polli, G. and Schaur, RJ. (2000) 4-hydroxynonenal in the pathomechanisms of oxidative stress. Life, 50, pp. 315-321.
11. Siems, W. and Grune, T. (2003) Intracellular metabolism of 4-hydroxynonenal. Mol Asp Med, 24, pp. 167-175.
12. Robles, R., Palomino, N. and Robles, A. (2001) Oxidative stress in the neonate. Early Human Dev, 65, pp. 75-81.
13. Tsukahara, H., Jiang, MZ, Ohta, N., Sato, S., Tamura, S., Hiraoka, M., Maeda, M. and Mazumi, M. (2004) Oxidative stress in neonates: Evaluation using specific biomarkers. Life Sci, 75, pp. 933-938.
14. Marzocchi, B., Perrone, S., Paffetti, P., Magi, B., Bini, L., Tani, C., Longini, M. and Buonocore, G. (2005) Nonprotein-bound iron and plasma protein oxidative stress at birth. Pediatr Res, 58, pp. 1295-1299.
15. Weinberger, B., Nisar, S., Anwar, M., Ostfeld, B. and Hegyi, T. (2006) Lipid peroxidation in cord blood and neonatal outcome. Pediatr Int, 48, pp. 479-483.
16. Rogers, MS, Mongelli, M., Tsang, KH and Wang, CC. (1999) Fetal and maternal levels of lipid peroxides in term pregnancies. Acta Obst Gynecol Scand, 78, pp. 120-124.
17. Ishihara, O., Hayashi, M., Osawa, H., Kobayashi, K., Takeda, S., Vessby, B. and Basu, S. (2004) Isoprostanes, prostaglandins and tocopherols in pre-eclampsia, normal pregnancy and non-pregnancy. Free Radic Res, 38, pp. 913-918.
18. Steinerova, A., Racek, J., Stozicky, F., Tatzber, F. and Lapin, A. (1999) Autoantibodies against oxidized LDL in the first phase of life. Clin Chem Lab Med, 37, pp. 913-917.
19. Shoji, H. and Koletzko, B. (2007) Oxidative stress and antioxidant protection in the perinatal period. Curr Opin Clin Nutr Metab Care, 10, pp. 324-328.
20. Karowicz-Billinska, A., Kowalska-Koprek, U., Suzin, J. and Sieroszewski, P. (2001) Schiff bases and malondialdehyde as parameters of lipid peroxidation in the pregnant women and the fetus. Prenat Neonat Med, 6, pp. 145-150.
21. Gupta, P., Narang, M., Banerjee, BD and Basu, S. (2004) Oxidative stress in term small for gestational age neonates born to undernourished mothers: A case control study. BMC Pediatrics, 4, pp. 14-21.
22. Arends, NJT, Boonstra, VH, Duivenvoordent, HJ, Hofman, PL, Cutfield, WS and Hokken-Koelega, ACS. (2005) Reduced insulin sensitivity and the presence of cardiovascular risk factors in short prepubertal children born small for gestational age (SGA). Clin Endocrin, 62, pp. 44-50.
23. Levvy-Marchal, C. and Czernichow, P. (2006) Small for gestational age and the metabolic syndrome: Which mechanisms is suggested by epidemiological and clinical studies?. Horm Res, 65, pp. 123-130.
24. Drougia, A., Giapros, V., Krallis, N., Theocharis, P., Nikaki, A., Tzoufi, M. and Andrnikou, S. (2007) Incidence and risk factors for cerebral palsy in infants with perinatal problems: A 15-year review. Early Hum Dev, 83, pp. 541-557.
25. Weinberger, B., Anwar, M., Henien, S., Sosnovsky, A., Hiatt, M., Jochnowitz, N., Witz, G. and Hegyi, T. (2004) Association of lipid peroxidation with antenatal betamethasone and oxygen radical disorders in preterm infants. Biol Neonate, 85, pp. 121-127.
26. Haynes, RL, Baud, LJ, Kinney, HC, Volpe, JJ and Folkerth, RD. (2005) Oxidative and nitrative injury in periventricular leukomalacia: A review. Brain Pathol, 15, pp. 225-233.
27. Franco, MCP, Kawamotto, EM, Gorjao, R., Rastelli, VMF, Curi, R., Scavone, C., Sawaya, AL, Fortes, ZB and Sesso, R. (2007) Biomarkers of oxidative stress and antioxidant status in children born small for gestational age: Evidence of lipid peroxidation. Pediatr Res, 62, pp. 204-208.
28. Mohn, A., Chiavaroli, V., Cerruto, M., Blasetti, A., Giannini, C., Bucciarelli, T. and Chiarelli, F. (2007) Increased oxidative stress in prepubertal children born small for gestational age. J Clin Endocrinol Metab, 92, pp. 1372-1378.
29. Hillestrom, PR, Weimann, A., Jensen, CB, Storgaard, H., Vaag, AA and Poulsen, HE. (2006) Consequences of low birthweight on urinary excretion of DNA markers of oxidative stress in young men. Scand J Clin Lab Invest, 66, pp. 363-370.
30. Khoschsorur, GA, Winklhofer-Roob, BM, Rabl, H., Auer, Th, Peng, Z. and Schaur, RJ. (2000) Evaluation of a sensitive HPLC method for determination of malondialdehyde, and application of the method to different biological materials. Chromatographia, 52, pp. 181-184.
31. Resch, U., Tatzber, F., Budinsky, A. and Sinzinger, H. (2005) Reduction of oxidative stress and modulation of autoantibodies against modified low-density lipoprotein after risuvastatin therapy. Br J Clin Pharmacol, 61, pp. 262-274.
32. Tatzber, F., Griebenow, S., Wonisch, W. and Winkler, R. (2003) Dual method for the determination of peroxidase activity and total peroxides-iodide leads to a significant increase of peroxidase activity in human sera. Ann Biochem, 316, pp. 147-153.
33. Waeg, G., Dimisity, G. and Esterbauer, H. (1996) Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free Radic Res, 25, pp. 149-159.
34. Borovic, S., Rabuzin, F., Waeg, G. and Zarkovic, N. (2006) Enzyme-linked immunosorbent assay for 4-hydroxynonenal-protein conjugates Free Radic Res, 40, pp. 809-820.
35. Zivkovic, M., Zarkovic, K., Skrinjar, L., Waeg, G., Poljak-Blazi, M., Borovic-Sunjic, S., Schaur, RJ and Zarkovic, N. (2005) A new method for detection of HNE-histidine conjugate intracellular s in rat inflammatory cells. Croat Chem Acta, 78, pp. 91-98.
36. Yelisyeyeva, O., Cherkas, A., Zarkovic, K., Semen, K., Kaminskyy, D., Waeg, G. and Zarkovic, N. (2008) The distribution of 4-hydroxynonenal-modified proteins in gastric mucosa of duodenal peptic ulcer patients. Free Radic Res, 42, pp. 205-211.
37. Sridhar, MG, Setia, S., John, M., Bhat, V., Nandeesha, H. and Sathiyapriya, V. (2007) Oxidative stress varies the mode of delivery in intrauterine growth retardation: Association with Apgar score. Clin Biochem, 40, pp. 688-691.
38. Arguelles, S., Machado, MJ, Ayala, A., Machado, A. and Hervias, B. (2006) Correlation between circulating biomarkers of oxidative stress of maternal and umbilical cord blood at birth. Free Radic Res, 40, pp. 565-570.
39. Kim, YJ, Hong, YC, Lee, KH, Park, HJ, Park, EA, Moon, HS and Ha, EH. (2005) Oxidative stress in pregnant women and birth weight reduction. Reprod Toxicol, 19, pp. 487-492.
40. Koarchazhkina, O., Jones, E., Szauderna, M. and Spencer, SA. (2006) Effects of exclusive formula or breast milk feeding on oxidative stress in healthy preterm infants. Arch Dis Child, 92, pp. 327-329.
41. Quiles, JL, Ochoa, JJ, Ramirez-Tortosa, MC, Linde, J., Bompadre, S., Battino, M., Narbona, E., Maldonado, J. and Mataix, J. (2006) Coenzyme Q concentration and total antioxidant capacity of human milk at different stages of lactation in mothers of preterm and full-term infants. Free Radic Res, 40, pp. 199-206.
42. Aycicek, A., Erel, O., Kocyigit, A., Selek, S. and Demirkol, MR. (2006) Breast milk provides better antioxidant power than does formula. Nutrition, 22, pp. 616-619.
43. Wang, W., Pang, CCP, Rogers, MS and Chang, AMZ. (1996) Lipid peroxidation in cord blood at birth. Am J Obstet Gynecol, 174, pp. 62-65.
44. Rogers, MS, Wang, W., Mongelli, M., Pang, CP, Duley, JA and Chang, AMZ. (1997) Lipid peroxidation in cord blood at birth: A marker of fetal hypoxia during labor. Gynecol Obstet Invest, 44, pp. 229-233.
45. Aycicek, A. and Iscan, A. (2006) Oxidative and antioxidative capacity in children with cerebral palsy. Brain Res Bull, 69, pp. 666-668.
46. Zarkovic, N., Ilic, Z., Jurin, M., Scahur, RJ, Puhl, H. and Esterbauer, H. (1993) Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochem Func, 11, pp. 279-286.
47. Zarkovic, N., Schaur, RJ, Puhl, H., Jurin, M. and Esterbauer, H. (1994) Mutual dependence of growth modifying effects of 4-hydroxy-nonenal and fetal calf serum in vitro. Free Radic Biol Med, 16, pp. 877-884.